Michal Peller
Overview
Explore the profile of Michal Peller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Krzowski B, Madyniak K, Peller M, Budnik M, Lodzinski P, Balsam P
Pol Arch Intern Med
. 2025 Jan;
PMID: 39807962
No abstract available.
2.
Maciejewski C, Lewandowska E, Peller M, Kowalik R, Grabowski M, Balsam P
Pol Arch Intern Med
. 2024 Dec;
135(2).
PMID: 39688587
No abstract available.
3.
Krzowski B, Jablonska M, Peller M, Marchel M, Lodzinski P, Balsam P
Kardiol Pol
. 2024 Nov;
83(1):91-93.
PMID: 39535951
No abstract available.
4.
Peller M, Dzwinacka J, Krzowski B, Marchel M, Maciejewski C, Mitrzak K, et al.
Kardiol Pol
. 2024 Oct;
83(1):35-42.
PMID: 39377617
Background: Pulmonary vein isolation is the cornerstone of atrial fibrillation treatment. First-pass pulmonary vein isolation is defined as isolation achieved with only a single lesion in every part of the...
5.
Wieteska-Milek M, Witowicz A, Szmit S, Florczyk M, Peller M, Dzienisiewicz M, et al.
J Clin Med
. 2024 Jun;
13(12).
PMID: 38930062
There was increased risk of mental disturbances during the COVID-19 pandemic. Patients with chronic diseases, including pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), were particularly vulnerable. Our...
6.
Peller M, Wawrzenczyk M, Ciecierski P, Balsam P, Marchel M, Krzowski B, et al.
Pol Arch Intern Med
. 2024 Feb;
134(4).
PMID: 38324391
Introduction: Pulmonary vein isolation (PVI) is a recommended strategy for rhythm control in atrial fibrillation (AF), but its success rate remains unsatisfactory. Continuous research is being conducted to explore new...
7.
Styczkiewicz M, Wawrzenczyk M, Peller M, Krzowski B, Maciejewski C, Lodzinski P, et al.
Int J Cardiol Heart Vasc
. 2023 Dec;
49:101306.
PMID: 38076348
Background Chronic kidney disease (CKD) coexisting with atrial fibrillation (AF) increases the risk of hemorrhage and ischemia. The study aimed to determine the relationship between different CKD stages and clinical...
8.
Wybraniec M, Maciag A, Miskowiec D, Ceynowa-Sielawko B, Balsam P, Wojcik M, et al.
Kardiol Pol
. 2023 Nov;
81(11):1089-1095.
PMID: 37997824
Background: Data on sex differences in terms of action of antiarrhythmic agents (AADs) are limited. This study aimed to evaluate the clinical profile of patients with atrial fibrillation (AF), and...
9.
Lembas A, Zaleski A, Peller M, Mikula T, Wiercinska-Drapalo A
Cardiovasc Toxicol
. 2023 Nov;
24(1):1-14.
PMID: 37982976
The developments in HIV treatments have increased the life expectancy of people living with HIV (PLWH), a situation that makes cardiovascular disease (CVD) in that population as relevant as ever....
10.
Boszko M, Krzowski B, Peller M, Hoffman P, Zurawska N, Skoczylas K, et al.
Life (Basel)
. 2023 Oct;
13(10).
PMID: 37895396
mHealth solutions optimize cardiovascular risk factor control in coronary artery disease. The aim of this study was to investigate the influence of mobile app AfterAMI on quality of life in...